5 ms·
No amount of capital can cut through the corruption and regulatory morass that has been built up over decades between the biopharma and government revolving doo
by gorwell 3y ago
No amount of capital can cut through the corruption and regulatory morass that has been built up over decades between the biopharma and government revolving door. That needs to get cleaned up before anyone has any chance of solving this.
https://www.modernhealthcare.com/assets/png/CH107294927.PNG https://www.modernhealthcare.com/assets/png/CH107294927.PNG
- mgiampapa 3y agoIsn't that exactly what Mark Cuban is doing with Cost Plus Drugs Company?
- TaylorAlexander 3y agoI am sure there is room to improve things on the corporate side but I also feel that we need major structural changes on the government side. Both parties receive significant funding from insurance companies and both parties are so pro-corporate that it’s hard to find any viable candidates who will oppose expansion of bureaucracy as long as doing so ensures more profits. The real problems are systemic.
- pasttense01 3y agoCost Plus Drugs overwhelmingly just deals with generic drugs, but generic drugs are just a small fraction of total drug costs.
- ethanbond 3y agoPharmaceuticals are a shockingly small part of the spend in healthcare in the US. Like ~10%.